Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-16

Clinical Trial Update: Trial of INI-2004 in Healthy Volunteers and Participants With Allergic Rhinitis. [Phase 1]

View source ↗

Summary

INI-2004 is being evaluated in a Phase 1 trial in healthy volunteers and participants with allergic rhinitis (weed pollen–associated). The study status is compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INI-2004 (INI-2004)

Snippet

Sponsor: Inimmune Corporation | Conditions: Allergic Rhinitis Due to Weed Pollen, Allergic Rhinitis | Phase 1 | Status: COMPLETED